Structure

Physi-Chem Properties

Molecular Weight:  572.23
Volume:  566.175
LogP:  3.092
LogD:  2.785
LogS:  -4.135
# Rotatable Bonds:  9
TPSA:  128.21
# H-Bond Aceptor:  11
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.367
Synthetic Accessibility Score:  4.401
Fsp3:  0.467
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.776
MDCK Permeability:  2.986047365993727e-05
Pgp-inhibitor:  0.997
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.009
20% Bioavailability (F20%):  0.001
30% Bioavailability (F30%):  0.054

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.106
Plasma Protein Binding (PPB):  72.58394622802734%
Volume Distribution (VD):  1.144
Pgp-substrate:  19.013290405273438%

ADMET: Metabolism

CYP1A2-inhibitor:  0.061
CYP1A2-substrate:  0.985
CYP2C19-inhibitor:  0.92
CYP2C19-substrate:  0.884
CYP2C9-inhibitor:  0.873
CYP2C9-substrate:  0.706
CYP2D6-inhibitor:  0.2
CYP2D6-substrate:  0.217
CYP3A4-inhibitor:  0.924
CYP3A4-substrate:  0.915

ADMET: Excretion

Clearance (CL):  4.754
Half-life (T1/2):  0.115

ADMET: Toxicity

hERG Blockers:  0.117
Human Hepatotoxicity (H-HT):  0.346
Drug-inuced Liver Injury (DILI):  0.842
AMES Toxicity:  0.055
Rat Oral Acute Toxicity:  0.195
Maximum Recommended Daily Dose:  0.06
Skin Sensitization:  0.105
Carcinogencity:  0.043
Eye Corrosion:  0.003
Eye Irritation:  0.118
Respiratory Toxicity:  0.491

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC308739

Natural Product ID:  NPC308739
Common Name*:   Kadsurarin
IUPAC Name:   n.a.
Synonyms:   Kadsurarin
Standard InCHIKey:  DHEFJFKRWXSOLG-XKIHEKSBSA-N
Standard InCHI:  InChI=1S/C30H36O11/c1-10-14(2)29(32)41-28-18-12-19(34-6)24(35-7)26(36-8)22(18)21-17(11-20-25(27(21)37-9)39-13-38-20)23(40-16(4)31)15(3)30(28,5)33/h10-12,15,23,28,33H,13H2,1-9H3/b14-10-/t15-,23-,28+,30-/m0/s1
SMILES:  C/C=C(/C)C(=O)O[C@@H]1c2cc(c(c(c2-c2c(cc3c(c2OC)OCO3)[C@H]([C@H](C)[C@]1(C)O)OC(=O)C)OC)OC)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL464501
PubChem CID:   44567619
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000238] Tannins
        • [CHEMONTID:0001710] Hydrolyzable tannins

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO18146 Kadsura angustifolia Species Schisandraceae Eukaryota stems Honghe Prefecture of Yunnan Province, China 2005-Oct PMID[18278869]
NPO18146 Kadsura angustifolia Species Schisandraceae Eukaryota n.a. n.a. n.a. PMID[21232955]
NPO18146 Kadsura angustifolia Species Schisandraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO18146 Kadsura angustifolia Species Schisandraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1452 Cell Line C8166 Homo sapiens CC50 > 200000.0 nM PMID[560035]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 168310.0 nM PMID[560035]
NPT2 Others Unspecified Ratio > 2.14 n.a. PMID[560035]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC308739 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC77237
1.0 High Similarity NPC217708
1.0 High Similarity NPC16791
1.0 High Similarity NPC126405
1.0 High Similarity NPC53669
1.0 High Similarity NPC297271
0.9862 High Similarity NPC224472
0.9796 High Similarity NPC198461
0.9732 High Similarity NPC475592
0.973 High Similarity NPC476065
0.9728 High Similarity NPC24562
0.9655 High Similarity NPC327352
0.9655 High Similarity NPC252281
0.9655 High Similarity NPC477375
0.9655 High Similarity NPC198129
0.9589 High Similarity NPC322426
0.9589 High Similarity NPC477374
0.9589 High Similarity NPC477376
0.9586 High Similarity NPC295297
0.9533 High Similarity NPC473323
0.953 High Similarity NPC312763
0.9527 High Similarity NPC471154
0.9524 High Similarity NPC316989
0.9463 High Similarity NPC474606
0.9459 High Similarity NPC475756
0.9456 High Similarity NPC85141
0.9448 High Similarity NPC318286
0.9448 High Similarity NPC327651
0.9408 High Similarity NPC230531
0.9408 High Similarity NPC215400
0.9404 High Similarity NPC29727
0.9392 High Similarity NPC470916
0.9388 High Similarity NPC316676
0.9388 High Similarity NPC325720
0.9384 High Similarity NPC321958
0.9384 High Similarity NPC321696
0.9379 High Similarity NPC326144
0.9338 High Similarity NPC238834
0.9333 High Similarity NPC477377
0.9324 High Similarity NPC474347
0.9324 High Similarity NPC474393
0.931 High Similarity NPC218510
0.931 High Similarity NPC76415
0.9295 High Similarity NPC118162
0.9295 High Similarity NPC83049
0.9295 High Similarity NPC320471
0.9272 High Similarity NPC473425
0.9267 High Similarity NPC475229
0.9267 High Similarity NPC477378
0.9262 High Similarity NPC473989
0.9189 High Similarity NPC137352
0.9189 High Similarity NPC183083
0.915 High Similarity NPC477380
0.9145 High Similarity NPC348849
0.9145 High Similarity NPC178195
0.9133 High Similarity NPC477381
0.9114 High Similarity NPC79322
0.9097 High Similarity NPC63061
0.9091 High Similarity NPC477885
0.9079 High Similarity NPC149735
0.9073 High Similarity NPC477379
0.9057 High Similarity NPC88557
0.9048 High Similarity NPC324962
0.9034 High Similarity NPC201404
0.9034 High Similarity NPC290714
0.9034 High Similarity NPC53722
0.902 High Similarity NPC473736
0.9 High Similarity NPC477883
0.8994 High Similarity NPC311912
0.8993 High Similarity NPC474054
0.8986 High Similarity NPC87883
0.8986 High Similarity NPC121661
0.8986 High Similarity NPC73467
0.898 High Similarity NPC36531
0.898 High Similarity NPC103637
0.898 High Similarity NPC230538
0.898 High Similarity NPC229172
0.8966 High Similarity NPC865
0.8954 High Similarity NPC475141
0.8947 High Similarity NPC303519
0.8926 High Similarity NPC166506
0.8926 High Similarity NPC110763
0.8926 High Similarity NPC475868
0.8926 High Similarity NPC197352
0.8926 High Similarity NPC189239
0.8917 High Similarity NPC319749
0.891 High Similarity NPC325122
0.8889 High Similarity NPC477881
0.8882 High Similarity NPC24425
0.8874 High Similarity NPC477879
0.8867 High Similarity NPC154971
0.8867 High Similarity NPC252286
0.8861 High Similarity NPC280778
0.8861 High Similarity NPC469512
0.8859 High Similarity NPC172171
0.8859 High Similarity NPC239254
0.8851 High Similarity NPC184641
0.8851 High Similarity NPC287124
0.8851 High Similarity NPC133934
0.8851 High Similarity NPC184684
0.8805 High Similarity NPC469475
0.8805 High Similarity NPC469518
0.88 High Similarity NPC477702
0.8797 High Similarity NPC191352
0.8797 High Similarity NPC258322
0.879 High Similarity NPC173726
0.879 High Similarity NPC241600
0.8767 High Similarity NPC143895
0.8766 High Similarity NPC302610
0.8759 High Similarity NPC145722
0.8759 High Similarity NPC185680
0.8759 High Similarity NPC256776
0.875 High Similarity NPC477884
0.875 High Similarity NPC304821
0.8742 High Similarity NPC212890
0.8742 High Similarity NPC42797
0.8733 High Similarity NPC166884
0.8733 High Similarity NPC141569
0.8733 High Similarity NPC477701
0.8727 High Similarity NPC477882
0.8727 High Similarity NPC477880
0.8718 High Similarity NPC117154
0.871 High Similarity NPC474514
0.8688 High Similarity NPC475865
0.8688 High Similarity NPC291977
0.8649 High Similarity NPC471183
0.8642 High Similarity NPC471180
0.8639 High Similarity NPC32189
0.8639 High Similarity NPC11453
0.8627 High Similarity NPC252402
0.8627 High Similarity NPC93924
0.8627 High Similarity NPC102934
0.8625 High Similarity NPC473445
0.8621 High Similarity NPC102256
0.8616 High Similarity NPC474770
0.8608 High Similarity NPC207584
0.8608 High Similarity NPC19947
0.8598 High Similarity NPC178737
0.8598 High Similarity NPC471181
0.8591 High Similarity NPC103448
0.8591 High Similarity NPC216434
0.859 High Similarity NPC245948
0.8581 High Similarity NPC477700
0.8581 High Similarity NPC32079
0.8571 High Similarity NPC236522
0.8562 High Similarity NPC152424
0.8562 High Similarity NPC100465
0.8553 High Similarity NPC328122
0.8552 High Similarity NPC184928
0.8552 High Similarity NPC141493
0.8544 High Similarity NPC32373
0.8544 High Similarity NPC237946
0.8526 High Similarity NPC220577
0.8526 High Similarity NPC470264
0.8519 High Similarity NPC222531
0.8514 High Similarity NPC133025
0.8509 High Similarity NPC61141
0.8509 High Similarity NPC249070
0.8506 High Similarity NPC270751
0.85 High Similarity NPC150943
0.85 High Similarity NPC268718
0.85 High Similarity NPC91634
0.85 High Similarity NPC96593
0.8491 Intermediate Similarity NPC115281
0.8491 Intermediate Similarity NPC181168
0.8491 Intermediate Similarity NPC163527
0.8487 Intermediate Similarity NPC187774
0.8487 Intermediate Similarity NPC472712
0.8487 Intermediate Similarity NPC18211
0.8487 Intermediate Similarity NPC143092
0.8487 Intermediate Similarity NPC297342
0.8487 Intermediate Similarity NPC472713
0.8487 Intermediate Similarity NPC475000
0.8487 Intermediate Similarity NPC473046
0.8487 Intermediate Similarity NPC474036
0.8487 Intermediate Similarity NPC118385
0.8485 Intermediate Similarity NPC469506
0.8477 Intermediate Similarity NPC41782
0.8477 Intermediate Similarity NPC474295
0.8467 Intermediate Similarity NPC46591
0.8467 Intermediate Similarity NPC177868
0.8462 Intermediate Similarity NPC13985
0.8462 Intermediate Similarity NPC210642
0.8456 Intermediate Similarity NPC301765
0.8456 Intermediate Similarity NPC46277
0.8456 Intermediate Similarity NPC474039
0.8456 Intermediate Similarity NPC156948
0.8456 Intermediate Similarity NPC283949
0.8456 Intermediate Similarity NPC3072
0.8456 Intermediate Similarity NPC86605
0.8452 Intermediate Similarity NPC293757
0.8452 Intermediate Similarity NPC477695
0.8452 Intermediate Similarity NPC90896
0.8452 Intermediate Similarity NPC668
0.8452 Intermediate Similarity NPC474965
0.8452 Intermediate Similarity NPC283839
0.8452 Intermediate Similarity NPC174512
0.8452 Intermediate Similarity NPC106138
0.8452 Intermediate Similarity NPC477698
0.8447 Intermediate Similarity NPC288149

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC308739 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.859 High Similarity NPD37 Approved
0.8553 High Similarity NPD6234 Discontinued
0.8544 High Similarity NPD4967 Phase 2
0.8544 High Similarity NPD4966 Approved
0.8544 High Similarity NPD4965 Approved
0.8333 Intermediate Similarity NPD7199 Phase 2
0.8303 Intermediate Similarity NPD7228 Approved
0.8232 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.8107 Intermediate Similarity NPD7240 Approved
0.7987 Intermediate Similarity NPD1653 Approved
0.7925 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.787 Intermediate Similarity NPD3818 Discontinued
0.7862 Intermediate Similarity NPD3705 Approved
0.7816 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7806 Intermediate Similarity NPD7266 Discontinued
0.78 Intermediate Similarity NPD3027 Phase 3
0.7758 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7736 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7719 Intermediate Similarity NPD5844 Phase 1
0.7707 Intermediate Similarity NPD6674 Discontinued
0.7706 Intermediate Similarity NPD7473 Discontinued
0.7674 Intermediate Similarity NPD7074 Phase 3
0.7636 Intermediate Similarity NPD1465 Phase 2
0.7633 Intermediate Similarity NPD6232 Discontinued
0.7616 Intermediate Similarity NPD7054 Approved
0.759 Intermediate Similarity NPD3817 Phase 2
0.7586 Intermediate Similarity NPD6559 Discontinued
0.7572 Intermediate Similarity NPD7472 Approved
0.7557 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD1613 Approved
0.7532 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD7819 Suspended
0.7486 Intermediate Similarity NPD7685 Pre-registration
0.747 Intermediate Similarity NPD1934 Approved
0.7446 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7443 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7443 Intermediate Similarity NPD7808 Phase 3
0.744 Intermediate Similarity NPD3882 Suspended
0.7434 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.743 Intermediate Similarity NPD6843 Phase 3
0.743 Intermediate Similarity NPD6842 Approved
0.743 Intermediate Similarity NPD6841 Approved
0.7419 Intermediate Similarity NPD4060 Phase 1
0.7412 Intermediate Similarity NPD5494 Approved
0.7403 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7396 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7396 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7386 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7386 Intermediate Similarity NPD7251 Discontinued
0.7372 Intermediate Similarity NPD6355 Discontinued
0.7368 Intermediate Similarity NPD8127 Discontinued
0.7358 Intermediate Similarity NPD5763 Approved
0.7358 Intermediate Similarity NPD5762 Approved
0.733 Intermediate Similarity NPD6797 Phase 2
0.7329 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7326 Intermediate Similarity NPD7229 Phase 3
0.7321 Intermediate Similarity NPD8455 Phase 2
0.7321 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7321 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD3018 Phase 2
0.7317 Intermediate Similarity NPD7314 Clinical (unspecified phase)
0.7317 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7294 Intermediate Similarity NPD7075 Discontinued
0.7287 Intermediate Similarity NPD7680 Approved
0.7257 Intermediate Similarity NPD3751 Discontinued
0.7256 Intermediate Similarity NPD2533 Approved
0.7256 Intermediate Similarity NPD2532 Approved
0.7256 Intermediate Similarity NPD2534 Approved
0.7247 Intermediate Similarity NPD7549 Discontinued
0.7241 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD6166 Phase 2
0.7241 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7232 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD3787 Discontinued
0.7222 Intermediate Similarity NPD3750 Approved
0.7219 Intermediate Similarity NPD2801 Approved
0.7213 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7195 Intermediate Similarity NPD6799 Approved
0.7178 Intermediate Similarity NPD6190 Approved
0.7171 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7171 Intermediate Similarity NPD2982 Phase 2
0.7171 Intermediate Similarity NPD2983 Phase 2
0.717 Intermediate Similarity NPD7097 Phase 1
0.7161 Intermediate Similarity NPD4908 Phase 1
0.716 Intermediate Similarity NPD1652 Phase 2
0.7152 Intermediate Similarity NPD5124 Phase 1
0.7152 Intermediate Similarity NPD230 Phase 1
0.7152 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD919 Approved
0.7143 Intermediate Similarity NPD4380 Phase 2
0.7143 Intermediate Similarity NPD7028 Phase 2
0.7143 Intermediate Similarity NPD6599 Discontinued
0.7125 Intermediate Similarity NPD3748 Approved
0.7123 Intermediate Similarity NPD5283 Phase 1
0.7119 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD4110 Phase 3
0.7117 Intermediate Similarity NPD4628 Phase 3
0.7117 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD4625 Phase 3
0.7115 Intermediate Similarity NPD7095 Approved
0.7111 Intermediate Similarity NPD8313 Approved
0.7111 Intermediate Similarity NPD8312 Approved
0.7105 Intermediate Similarity NPD2981 Phase 2
0.7091 Intermediate Similarity NPD4357 Discontinued
0.7088 Intermediate Similarity NPD8434 Phase 2
0.7086 Intermediate Similarity NPD3926 Phase 2
0.7081 Intermediate Similarity NPD2438 Suspended
0.7076 Intermediate Similarity NPD5353 Approved
0.7076 Intermediate Similarity NPD5402 Approved
0.707 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7067 Intermediate Similarity NPD5691 Approved
0.7067 Intermediate Similarity NPD1357 Approved
0.7059 Intermediate Similarity NPD6801 Discontinued
0.7047 Intermediate Similarity NPD5536 Phase 2
0.7039 Intermediate Similarity NPD1091 Approved
0.7039 Intermediate Similarity NPD422 Phase 1
0.7039 Intermediate Similarity NPD1610 Phase 2
0.7035 Intermediate Similarity NPD7768 Phase 2
0.7032 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7027 Intermediate Similarity NPD7296 Approved
0.702 Intermediate Similarity NPD4626 Approved
0.7018 Intermediate Similarity NPD5563 Clinical (unspecified phase)
0.701 Intermediate Similarity NPD8151 Discontinued
0.7 Intermediate Similarity NPD5090 Approved
0.7 Intermediate Similarity NPD5089 Approved
0.6994 Remote Similarity NPD3749 Approved
0.6989 Remote Similarity NPD5242 Approved
0.6988 Remote Similarity NPD1511 Approved
0.6987 Remote Similarity NPD2861 Phase 2
0.6982 Remote Similarity NPD7458 Discontinued
0.6982 Remote Similarity NPD6055 Clinical (unspecified phase)
0.6981 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6981 Remote Similarity NPD3620 Phase 2
0.6977 Remote Similarity NPD6374 Clinical (unspecified phase)
0.6975 Remote Similarity NPD2935 Discontinued
0.6975 Remote Similarity NPD6099 Approved
0.6975 Remote Similarity NPD6100 Approved
0.6971 Remote Similarity NPD6959 Discontinued
0.6964 Remote Similarity NPD5403 Approved
0.6963 Remote Similarity NPD5006 Approved
0.6963 Remote Similarity NPD5005 Approved
0.6962 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6962 Remote Similarity NPD6798 Discontinued
0.6951 Remote Similarity NPD5698 Clinical (unspecified phase)
0.6948 Remote Similarity NPD4749 Approved
0.6946 Remote Similarity NPD5401 Approved
0.6946 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6937 Remote Similarity NPD1933 Approved
0.6928 Remote Similarity NPD5058 Phase 3
0.6909 Remote Similarity NPD7982 Clinical (unspecified phase)
0.6909 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6905 Remote Similarity NPD1512 Approved
0.6903 Remote Similarity NPD1283 Approved
0.6901 Remote Similarity NPD7411 Suspended
0.6901 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6894 Remote Similarity NPD6653 Approved
0.689 Remote Similarity NPD2424 Discontinued
0.6882 Remote Similarity NPD4005 Discontinued
0.6882 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6879 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6875 Remote Similarity NPD4140 Approved
0.6875 Remote Similarity NPD2979 Phase 3
0.6875 Remote Similarity NPD1247 Approved
0.6871 Remote Similarity NPD2796 Approved
0.6867 Remote Similarity NPD5307 Clinical (unspecified phase)
0.6859 Remote Similarity NPD2797 Approved
0.6855 Remote Similarity NPD3764 Approved
0.6842 Remote Similarity NPD4420 Approved
0.6839 Remote Similarity NPD7435 Discontinued
0.6832 Remote Similarity NPD447 Suspended
0.6829 Remote Similarity NPD3540 Phase 1
0.6829 Remote Similarity NPD1375 Discontinued
0.6813 Remote Similarity NPD6233 Phase 2
0.681 Remote Similarity NPD7033 Discontinued
0.681 Remote Similarity NPD1510 Phase 2
0.681 Remote Similarity NPD4108 Discontinued
0.6807 Remote Similarity NPD3892 Phase 2
0.6807 Remote Similarity NPD8166 Discontinued
0.6805 Remote Similarity NPD6273 Approved
0.6802 Remote Similarity NPD6386 Approved
0.6802 Remote Similarity NPD6385 Approved
0.68 Remote Similarity NPD4055 Discovery
0.6797 Remote Similarity NPD5125 Phase 3
0.6797 Remote Similarity NPD5126 Approved
0.6788 Remote Similarity NPD1549 Phase 2
0.6776 Remote Similarity NPD1548 Phase 1
0.6774 Remote Similarity NPD1608 Approved
0.677 Remote Similarity NPD1240 Approved
0.6768 Remote Similarity NPD1551 Phase 2
0.6768 Remote Similarity NPD6032 Approved
0.6768 Remote Similarity NPD3539 Phase 1
0.6766 Remote Similarity NPD5084 Clinical (unspecified phase)
0.6765 Remote Similarity NPD920 Approved
0.676 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6753 Remote Similarity NPD3496 Discontinued
0.675 Remote Similarity NPD7985 Registered
0.675 Remote Similarity NPD1699 Clinical (unspecified phase)
0.675 Remote Similarity NPD7930 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data